Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by Reidism29on Jan 22, 2025 9:26pm
224 Views
Post# 36416269

Trading on the 15th

Trading on the 15thHello All. I'm a silent long, in since the beginning. I rarely post, but I appreciate reading your comments. I am still greatly mystified by the events of the 15th and looking for sensible explanations that will satisfy my need for understanding. It was a huge amount of dilution, from my position, and would require very strong justification. Dilution that would also impact management holdings. I am hoping it was justified by what will unfold.
Discussions on ATMs suggest that they are a good way for companies to trickle shares into the market without impacting price very much. 33M shares traded in one day, 27M in the pre-market, is astronomical (unheard of?) volume. Something like 100x daily average volume. The large majority of it in the pre-market, where relatively few sellers and buyers are present. In fact many brokerages only allow limit orders in after hours trading because of the associated volatility created by the thin market. Some don't even allow it.
So if ONC (or their agent) was flooding the pre-market with ATM shares, it should have cratered the price. They could use limit sell orders to establish a floor, but they would quickly exhaust the buy orders with those volumes, in that thin market. Unless there was a pre-arranged buyer present with the means and desire to soak up all that volume in a pre-arranged price band. Which smells like partner acquiring a significant stake in the company. (Q: Why not just do a bought deal financing? Possible A: Urgency?) My understanding is that they have to declare their intentions within 10 days when they cross the 5% threshold (Nasdaq). 5% would be roughly 4M shares, a fraction of what went down.
I would appreciate any other thoughts on what happened that day, and how it ties in to what may be going on behind the scenes now.
<< Previous
Bullboard Posts
Next >>